SLC6A3 and Parkinson disease: Indeed, in our earlier longitudinal PET studies of newly diagnosed PD patients11,12, we found that these individuals typically had PDRP expression values above + 1.5 and reductions in putamen DAT binding below 40% of the normal mean value11,12,24.